Connect with us

Health

PARAGON-HF: Sacubitril/valsartan reduces triglyceride levels in HFpEF – Healio

Sacubitril/valsartan drastically reduced triglycerides compared with valsartan in patients with HF with preserved ejection fraction, according to a presentation…

Published

on

Advertisement

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Sacubitril/valsartan drastically reduced triglycerides compared with valsartan in patients with HF with preserved ejection fraction, according to a presentation at the American College of Cardiology Scientific Session.
In the analysis from the PARAGON-HF study, simultaneously published in the Journal of the American Heart Association, the effect…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Convergent mechanism of aging discovered – Science Daily
Article feature image
Plan to end HIV transmission in Australia by 2025 – The Australian